Katherine A. Rouleau

753 total citations
17 papers, 548 citations indexed

About

Katherine A. Rouleau is a scholar working on Molecular Biology, Epidemiology and Physiology. According to data from OpenAlex, Katherine A. Rouleau has authored 17 papers receiving a total of 548 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 8 papers in Epidemiology and 8 papers in Physiology. Recurrent topics in Katherine A. Rouleau's work include Biochemical and Molecular Research (12 papers), Adenosine and Purinergic Signaling (8 papers) and Cytomegalovirus and herpesvirus research (7 papers). Katherine A. Rouleau is often cited by papers focused on Biochemical and Molecular Research (12 papers), Adenosine and Purinergic Signaling (8 papers) and Cytomegalovirus and herpesvirus research (7 papers). Katherine A. Rouleau collaborates with scholars based in United States, Sweden and Germany. Katherine A. Rouleau's co-authors include T J Brown, James Loy, Philip M. Wallace, Edwin J. Iwanowicz, Catherine Fleener, Diane Hollenbaugh, John F. MacMaster, Scott H. Watterson, T. G. Murali Dhar and Joel C. Barrish and has published in prestigious journals such as Blood, The Journal of Immunology and Annals of the New York Academy of Sciences.

In The Last Decade

Katherine A. Rouleau

17 papers receiving 543 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Katherine A. Rouleau United States 13 221 176 152 126 88 17 548
O Babuŝíková Slovakia 11 339 1.5× 132 0.8× 99 0.7× 47 0.4× 42 0.5× 83 677
Laia Rosich Spain 15 410 1.9× 134 0.8× 121 0.8× 29 0.2× 82 0.9× 21 721
Thomas G. Gesner United States 14 291 1.3× 185 1.1× 166 1.1× 84 0.7× 47 0.5× 16 602
Jonathan S. George United States 6 115 0.5× 154 0.9× 77 0.5× 85 0.7× 35 0.4× 7 471
Leena Vilpo Finland 17 205 0.9× 121 0.7× 226 1.5× 33 0.3× 21 0.2× 39 610
Grazia Carbotti Italy 12 217 1.0× 321 1.8× 309 2.0× 58 0.5× 29 0.3× 15 639
Patty Trobridge United States 11 262 1.2× 190 1.1× 134 0.9× 30 0.2× 64 0.7× 12 571
Nicole Rufo Belgium 9 188 0.9× 233 1.3× 309 2.0× 22 0.2× 72 0.8× 10 615
Indranil Basu United States 9 344 1.6× 158 0.9× 70 0.5× 21 0.2× 23 0.3× 17 543
James E. Gervasoni United States 10 393 1.8× 352 2.0× 46 0.3× 28 0.2× 24 0.3× 15 725

Countries citing papers authored by Katherine A. Rouleau

Since Specialization
Citations

This map shows the geographic impact of Katherine A. Rouleau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katherine A. Rouleau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katherine A. Rouleau more than expected).

Fields of papers citing papers by Katherine A. Rouleau

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Katherine A. Rouleau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katherine A. Rouleau. The network helps show where Katherine A. Rouleau may publish in the future.

Co-authorship network of co-authors of Katherine A. Rouleau

This figure shows the co-authorship network connecting the top 25 collaborators of Katherine A. Rouleau. A scholar is included among the top collaborators of Katherine A. Rouleau based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Katherine A. Rouleau. Katherine A. Rouleau is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Chen, Ping, Derek Norris, T. G. Murali Dhar, et al.. (2003). Identification of novel and potent isoquinoline aminooxazole-Based IMPDH inhibitors. Bioorganic & Medicinal Chemistry Letters. 13(7). 1345–1348. 21 indexed citations
2.
Watterson, Scott H., T. G. Murali Dhar, Zhongqi Shen, et al.. (2003). Novel inhibitors of IMPDH. Bioorganic & Medicinal Chemistry Letters. 13(3). 543–546. 23 indexed citations
3.
Dhar, T. G. Murali, Zhongqi Shen, Henry H. Gu, et al.. (2003). 3-Cyanoindole-based inhibitors of inosine monophosphate dehydrogenase: synthesis and initial structure–Activity relationships. Bioorganic & Medicinal Chemistry Letters. 13(20). 3557–3560. 31 indexed citations
4.
Dhar, T. G. Murali, Scott H. Watterson, Ping Chen, et al.. (2003). Quinolone-Based IMPDH inhibitors: introduction of basic residues on ring D and SAR of the corresponding mono, di and benzofused analogues. Bioorganic & Medicinal Chemistry Letters. 13(3). 547–551. 7 indexed citations
5.
Iwanowicz, Edwin J., Scott H. Watterson, Junqing Guo, et al.. (2003). Inhibitors of inosine monophosphate dehydrogenase: SARs about the N-[3-Methoxy-4-(5-oxazolyl)phenyl moiety. Bioorganic & Medicinal Chemistry Letters. 13(12). 2059–2063. 18 indexed citations
6.
Watterson, Scott H., T. G. Murali Dhar, Shelley K. Ballentine, et al.. (2003). Novel indole-based inhibitors of IMPDH: introduction of hydrogen bond acceptors at indole C-3. Bioorganic & Medicinal Chemistry Letters. 13(7). 1273–1276. 30 indexed citations
7.
Pitts, William J., Junqing Guo, T. G. Murali Dhar, et al.. (2002). Rapid synthesis of triazine inhibitors of inosine monophosphate dehydrogenase. Bioorganic & Medicinal Chemistry Letters. 12(16). 2137–2140. 31 indexed citations
8.
Iwanowicz, Edwin J., Scott H. Watterson, Chunjian Liu, et al.. (2002). Novel guanidine-Based inhibitors of inosine monophosphate dehydrogenase. Bioorganic & Medicinal Chemistry Letters. 12(20). 2931–2934. 18 indexed citations
9.
Dhar, T. G. Murali, Zhongqi Shen, Catherine Fleener, et al.. (2002). The TosMIC approach to 3-(Oxazol-5-yl) indoles: application to the synthesis of indole-based IMPDH inhibitors. Bioorganic & Medicinal Chemistry Letters. 12(22). 3305–3308. 16 indexed citations
10.
Watterson, Scott H., Chunjian Liu, T. G. Murali Dhar, et al.. (2002). Novel amide-based inhibitors of inosine 5′-monophosphate dehydrogenase. Bioorganic & Medicinal Chemistry Letters. 12(20). 2879–2882. 11 indexed citations
11.
Gu, Henry H., Edwin J. Iwanowicz, Junqing Guo, et al.. (2002). Novel diamide-Based inhibitors of IMPDH. Bioorganic & Medicinal Chemistry Letters. 12(9). 1323–1326. 17 indexed citations
12.
Dhar, T. G. Murali, Chunjian Liu, William J. Pitts, et al.. (2002). A survey of cyclic replacements for the central diamide moiety of inhibitors of inosine monophosphate dehydrogenase. Bioorganic & Medicinal Chemistry Letters. 12(21). 3125–3128. 11 indexed citations
13.
Wallace, Philip M., John F. MacMaster, Katherine A. Rouleau, et al.. (1999). Regulation of Inflammatory Responses by Oncostatin M. The Journal of Immunology. 162(9). 5547–5555. 98 indexed citations
14.
Rouleau, Katherine A., et al.. (1999). Regulation of inflammatory responses by oncostatin M.. PubMed. 162(9). 5547–55. 101 indexed citations
15.
McSweeney, Peter A., Katherine A. Rouleau, Philip M. Wallace, et al.. (1998). Characterization of Monoclonal Antibodies That Recognize Canine CD34. Blood. 91(6). 1977–1986. 4 indexed citations
16.
McSweeney, Peter A., Katherine A. Rouleau, Philip M. Wallace, et al.. (1998). Characterization of Monoclonal Antibodies That Recognize Canine CD34. Blood. 91(6). 1977–1986. 80 indexed citations
17.
Wallace, Philip M., John F. MacMaster, Jill R. Rillema, et al.. (1995). In VivoProperties of Oncostatin M. Annals of the New York Academy of Sciences. 762(1). 42–54. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026